The Transformation of Oncology Drug Development in China: Toward a New Phase of Innovation
- DOI
- 10.1158/2159-8290.cd-26-1628
- Published
- 2026-11-08
- Container
- Cancer Discovery
- Publisher
- American Association for Cancer Research (AACR)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1158/2159-8290.cd-26-1628,
title = {The Transformation of Oncology Drug Development in China: Toward a New Phase of Innovation},
author = {Yang Chen and Dan Liu and Yuanyuan Song and Yiming Luo and Chenglong Shi and Hongxi Zeng and Haoxin Peng and Yi Xie and Chenlin Cao and Ye Yuan and Kaijie Liang and Zhi Peng and Xiaotian Zhang and Zhihao Lu and Jifang Gong and Jian Li and Zhimin Yang and Lin Shen},
year = {2026},
journal = {Cancer Discovery},
doi = {10.1158/2159-8290.cd-26-1628},
url = {https://doi.org/10.1158/2159-8290.cd-26-1628}
}RIS
TY - JOUR TI - The Transformation of Oncology Drug Development in China: Toward a New Phase of Innovation AU - Yang Chen AU - Dan Liu AU - Yuanyuan Song AU - Yiming Luo AU - Chenglong Shi AU - Hongxi Zeng AU - Haoxin Peng AU - Yi Xie AU - Chenlin Cao AU - Ye Yuan AU - Kaijie Liang AU - Zhi Peng AU - Xiaotian Zhang AU - Zhihao Lu AU - Jifang Gong AU - Jian Li AU - Zhimin Yang AU - Lin Shen PY - 2026 JO - Cancer Discovery DO - 10.1158/2159-8290.cd-26-1628 UR - https://doi.org/10.1158/2159-8290.cd-26-1628 ER -
APA
Chen, Y., Liu, D., Song, Y., Luo, Y., Shi, C., Zeng, H., Peng, H., Xie, Y., Cao, C., Yuan, Y., Liang, K., Peng, Z., Zhang, X., Lu, Z., Gong, J., Li, J., Yang, Z., & Shen, L. (2026). The Transformation of Oncology Drug Development in China: Toward a New Phase of Innovation. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-26-1628
Source records
- crossref · retrieved 2026-11-10T01:08:25.453Z